NO980556D0 - Procedure for reducing the amount of exogenous insulin administered to a patient with non-insulin-dependent diabetes mellitus - Google Patents

Procedure for reducing the amount of exogenous insulin administered to a patient with non-insulin-dependent diabetes mellitus

Info

Publication number: NO980556D0
Authority: NO; Norway
Prior art keywords: insulin; patient; procedure; reducing; amount
Prior art date: 1995-08-10

Application number

NO980556A

Other languages

Norwegian (no)

Other versions

NO980556L (en

Inventor

Randall W Whitcomb

Original Assignee

Warner Lambert Co

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1995-08-10

Filing date

1998-02-09

Publication date

1998-02-09

1998-02-09 Application filed by Warner Lambert Co filed Critical Warner Lambert Co

1998-02-09 Publication of NO980556D0 publication Critical patent/NO980556D0/en

1998-02-09 Publication of NO980556L publication Critical patent/NO980556L/en

Links

NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 title 2
102000004877 Insulin Human genes 0.000 title 1
108090001061 Insulin Proteins 0.000 title 1
229940125396 insulin Drugs 0.000 title 1
208000001072 type 2 diabetes mellitus Diseases 0.000 title 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
- A61K31/426—1,3-Thiazoles
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
- A61K31/427—Thiazoles not condensed and containing further heterocyclic rings
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/28—Insulins
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones
- A61P5/50—Drugs for disorders of the endocrine system of the pancreatic hormones for increasing or potentiating the activity of insulin

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Epidemiology (AREA)
Diabetes (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Endocrinology (AREA)
Zoology (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
Chemical Kinetics & Catalysis (AREA)
Gastroenterology & Hepatology (AREA)
Immunology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Plural Heterocyclic Compounds (AREA)

NO980556A 1995-08-10 1998-02-09 Procedure for reducing the amount of exogenous insulin administered to a patient with non-insulin-dependent diabetes mellitus NO980556L (en)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US209895P	1995-08-10	1995-08-10
PCT/US1996/012430 WO1997005875A2 (en)	1995-08-10	1996-07-29	A method of reducing the amount of exogenous insulin administered to a patient having noninsulin-dependent diabetes mellitus

Publications (2)

Publication Number	Publication Date
NO980556D0 true NO980556D0 (en)	1998-02-09
NO980556L NO980556L (en)	1998-02-09

Family

ID=21699238

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO980556A NO980556L (en)	1995-08-10	1998-02-09	Procedure for reducing the amount of exogenous insulin administered to a patient with non-insulin-dependent diabetes mellitus

Country Status (15)

Country	Link
EP (1)	EP0851757A2 (en)
JP (1)	JPH11510508A (en)
KR (1)	KR19990036290A (en)
CN (1)	CN1192683A (en)
AU (1)	AU724989B2 (en)
BG (1)	BG102235A (en)
CA (1)	CA2221241A1 (en)
CZ (1)	CZ32998A3 (en)
EA (1)	EA199800177A1 (en)
HU (1)	HUP9802543A2 (en)
IL (1)	IL122191A0 (en)
NO (1)	NO980556L (en)
NZ (1)	NZ313874A (en)
SK (1)	SK16498A3 (en)
WO (1)	WO1997005875A2 (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB9711683D0 (en) *	1997-06-05	1997-08-06	Smithkline Beecham Plc	Composition
GB9712866D0 (en) *	1997-06-18	1997-08-20	Smithkline Beecham Plc	Novel method of treatment
GB2335597A (en) *	1998-03-27	1999-09-29	Glaxo Group Ltd	Stereoisomers of Troglitazone in the Treatment of Diabetes
US7045519B2 (en)	1998-06-19	2006-05-16	Chiron Corporation	Inhibitors of glycogen synthase kinase 3
CN1312807A (en)	1998-06-19	2001-09-12	希龙公司	Inhibitors of glycogen synthase kinase 3
FR2838968A1 (en) *	2002-04-30	2003-10-31	Lipha	ASSOCIATION OF INSULIN AND A THIAZOLIDINEDIONE DERIVATIVE AND USE THEREOF FOR TREATING DIABETES

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JPS6051189A (en) *	1983-08-30	1985-03-22	Sankyo Co Ltd	Thiazolidine derivative and its preparation
US4873255A (en) *	1987-02-04	1989-10-10	Sankyo Company Limited	Thiazolidinone derivatives, their preparation and their use
US5478852C1 (en) *	1993-09-15	2001-03-13	Sankyo Co	Use of thiazolidinedione derivatives and related antihyperglycemic agents in the treatment of impaired glucose tolerance in order to prevent or delay the onset of noninsulin-dependent diabetes mellitus
TWI238064B (en)	1995-06-20	2005-08-21	Takeda Chemical Industries Ltd	A pharmaceutical composition for prophylaxis and treatment of diabetes

1996
- 1996-07-29 JP JP9508479A patent/JPH11510508A/en not_active Ceased
- 1996-07-29 CN CN96196191A patent/CN1192683A/en active Pending
- 1996-07-29 WO PCT/US1996/012430 patent/WO1997005875A2/en not_active Ceased
- 1996-07-29 AU AU66411/96A patent/AU724989B2/en not_active Withdrawn - After Issue
- 1996-07-29 HU HU9802543A patent/HUP9802543A2/en unknown
- 1996-07-29 KR KR1019980700958A patent/KR19990036290A/en not_active Ceased
- 1996-07-29 CA CA002221241A patent/CA2221241A1/en not_active Abandoned
- 1996-07-29 EP EP96926171A patent/EP0851757A2/en not_active Withdrawn
- 1996-07-29 SK SK164-98A patent/SK16498A3/en unknown
- 1996-07-29 IL IL12219196A patent/IL122191A0/en unknown
- 1996-07-29 CZ CZ98329A patent/CZ32998A3/en unknown
- 1996-07-29 EA EA199800177A patent/EA199800177A1/en unknown
- 1996-07-29 NZ NZ313874A patent/NZ313874A/en unknown
1998
- 1998-02-05 BG BG102235A patent/BG102235A/en unknown
- 1998-02-09 NO NO980556A patent/NO980556L/en not_active Application Discontinuation

Also Published As

Publication number	Publication date
KR19990036290A (en)	1999-05-25
CZ32998A3 (en)	1998-10-14
HUP9802543A2 (en)	1999-07-28
BG102235A (en)	1998-09-30
AU724989B2 (en)	2000-10-05
WO1997005875A3 (en)	1997-03-27
AU6641196A (en)	1997-03-05
EA199800177A1 (en)	1998-10-29
CA2221241A1 (en)	1997-02-20
SK16498A3 (en)	1999-03-12
WO1997005875A2 (en)	1997-02-20
CN1192683A (en)	1998-09-09
EP0851757A2 (en)	1998-07-08
NO980556L (en)	1998-02-09
NZ313874A (en)	2000-09-29
JPH11510508A (en)	1999-09-14
IL122191A0 (en)	1998-04-05

Publication	Publication Date	Title
PH23014A (en)	1989-03-03	Novel insulin derivatives,their use and pharmaceutical agents for the treatment of diabetes mellitus
CA2024502A1 (en)	1991-03-06	Dosage form for administering oral hypoglycemic glipizide
IL133643A0 (en)	2001-04-30	Therapeutic method for management of diabetes mellitus
AU4741790A (en)	1990-06-12	Syringe adapted to prevent needle sticks
ATE126055T1 (en)	1995-08-15	NAPROXEN CONTROLLED ABSORPTION FORMULATION FOR ONCE DAILY USE.
AU4748990A (en)	1990-06-26	Hypodermic syringe
AU4057289A (en)	1990-03-05	Hypodermic syringe
WO2000041504A3 (en)	2000-11-09	Use of tertbutylhydroquinone for lowering blood cholesterol and/or blood triblycerides
AU1924795A (en)	1995-09-04	Treatment and/or prevention of type i diabetes mellitus with gamma interferon administration
NO980556D0 (en)	1998-02-09	Procedure for reducing the amount of exogenous insulin administered to a patient with non-insulin-dependent diabetes mellitus
CA2113856A1 (en)	1994-10-15	Antidiabetic Agent
HUP0003260A3 (en)	2001-12-28	Pharmaceutical composition for treatment of diabetes with rosiglitazone and insulin
AU5352190A (en)	1990-12-18	Single-use syringe for injections
GB8911818D0 (en)	1989-07-12	Single-use hypodermic syringe adaptor therefor
USD323030S (en)	1992-01-07	Medical syringe for administering subcutaneous injections
AU4967390A (en)	1990-11-16	Single-use syringe for injections
AU4846090A (en)	1990-08-01	Single-use medical needle
DK0785787T3 (en)	2002-03-11	Use of 1,5-benzodiazepine derivatives to control gastric emptying in patients with non-insulin-dependent diabetes mellitus
ES2181923T3 (en)	2003-03-01	4-HYDROXICUMARIN-3-CARBOXAMIDES FOR THE TREATMENT OF DIABET IS MELLITUS NOT INSULIN DEPENDENT.
ATE124627T1 (en)	1995-07-15	PHARMACEUTICAL COMPOSITION CONTAINING DICLOFENAC SODIUM FOR TOPICAL USE.
AU3751193A (en)	1993-10-21	Syringe for medical use with non-reusable automatically disappearing needle
MX9709958A (en)	1998-03-29	A method of reducing the amount of exogenous insulin administered to a patient having noninsulin-dependent diabetes mellitus.
AU4553593A (en)	1995-01-17	Treatment of diabetes using phosphorylated insulin
IL111361A0 (en)	1994-12-29	Pharmaceutical compositions for the treatment of insulin dependent diabetes mellitus (iddm)
AU6109894A (en)	1994-09-26	New disposable hypodermic syringe

Legal Events

Date	Code	Title	Description
2003-04-14	FC2A	Withdrawal, rejection or dismissal of laid open patent application